Your browser doesn't support javascript.
loading
High-throughput optofluidic screening of single B cells identifies novel cross-reactive antibodies as inhibitors of uPAR with antibody-dependent effector functions.
Lourenço, André Luiz; Chuo, Shih-Wei; Bohn, Markus F; Hann, Byron; Khan, Shireen; Yevalekar, Neha; Patel, Nitin; Yang, Teddy; Xu, Lina; Lv, Dandan; Drakas, Robert; Lively, Sarah; Craik, Charles S.
Affiliation
  • Lourenço AL; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, USA.
  • Chuo SW; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, USA.
  • Bohn MF; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, USA.
  • Hann B; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA.
  • Khan S; ChemPartner, South San Francisco, California, USA.
  • Yevalekar N; ChemPartner, South San Francisco, California, USA.
  • Patel N; ChemPartner, South San Francisco, California, USA.
  • Yang T; Shanghai ChemPartner Co Ltd, Shanghai, China.
  • Xu L; Shanghai ChemPartner Co Ltd, Shanghai, China.
  • Lv D; Shanghai ChemPartner Co Ltd, Shanghai, China.
  • Drakas R; ShangPharma Innovation Inc, South San Francisco, California, USA.
  • Lively S; ChemPartner, South San Francisco, California, USA.
  • Craik CS; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, USA.
MAbs ; 15(1): 2184197, 2023.
Article in En | MEDLINE | ID: mdl-36859773
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukocytes, Mononuclear / Receptors, Urokinase Plasminogen Activator Type of study: Diagnostic_studies / Screening_studies Limits: Animals / Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukocytes, Mononuclear / Receptors, Urokinase Plasminogen Activator Type of study: Diagnostic_studies / Screening_studies Limits: Animals / Humans Language: En Year: 2023 Type: Article